Comparative Analysis of the Hemodynamic Effects of Remimazolam and Propofol During General Anesthesia: A Retrospective Study
Authors:
Open Access
- 15 April 2024
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58340
Abstract
Purpose: Hypotension is common during anesthesia induction. However, minimal hemodynamic effects of remimazolam anesthesia have been reported. We hypothesized that remimazolam would have weaker hemodynamic effects than would propofol. To test this, we simultaneously evaluated the hemodynamics using the estimated continuous cardiac output (esCCO) system and heart rate variability (HRV) during anesthesia induction. Methods: This was a single-center, observational, retrospective study of patients undergoing dental surgery under general anesthesia between 2020 and 2022. Seventy patients were divided into two groups: remimazolam (R group; n=34) and propofol (P group; n=36). The information obtained from the anesthesia records, patient information, esCCO system parameters, and HRV were integrated and analyzed. The percentages of various parameters were set to 100% for the pre-induction phase as the baseline. Results: The %MAP (noninvasive mean arterial blood pressure) decreased over a narrower range in the R compared to the P group (-17.8% (-26.3%, -11.9%) vs. -22.6% (-32.9%, -17.0%); P=0.039). The %HR (heart rate) increased significantly in the R group and decreased in the P group (+10.7% (+6.5%, +18.6%) vs. -6.5% (-14.5%, +8.4%); P<0.01). The %SV esCCO (stroke volume calculated using the esCCO system) decreased significantly in both groups, but the R group showed a smaller difference compared to the P group (5.1% (7.7%, -2.1%) vs. -10.0% (-13.8%, -5.6%); P<0.01). The rates of change in %LF nu (normalized unit of low frequency) and %HF nu (normalized unit of high frequency) were lower for the R than for the P group, although the difference was not significant (+6.8% (-14.5%, 32.4%) vs. +9.2% (-7.2%, +59.7%), P=0.30; +7.9% (-51.0%, +66.9%) vs. +22.8% (-26.1%, +61.6%), P=0.57). Conclusion: Remimazolam demonstrated a lower MAP reduction rate than propofol. A compensatory increase in HR occurred with a decrease in stroke volume. However, the HR increase was not attributable to the autonomic nervous system.Keywords
This publication has 37 references indexed in Scilit:
- Differential effects of remimazolam and propofol on heart rate variability during anesthesia inductionJournal of Anesthesia, 2022
- Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double‐blind, controlled trialPharmacology Research & Perspectives, 2021
- Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trialJournal of Anesthesia, 2020
- Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational studyJournal of Anesthesia, 2018
- Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major SurgeryJAMA, 2017
- Effect of Heart Rate Variability Biofeedback on Sport Performance, a Systematic ReviewApplied Psychophysiology and Biofeedback, 2017
- The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistancesBritish Journal of Anaesthesia, 2016
- Comparison of the ability of two continuous cardiac output monitors to measure trends in cardiac output: estimated continuous cardiac output measured by modified pulse wave transit time and an arterial pulse contour-based cardiac output deviceJournal of Clinical Monitoring and Computing, 2015
- Interpretation of Normalized Spectral Heart Rate Variability Indices In Sleep Research: A Critical ReviewSLEEP, 2007
- A New Non-Invasive Continuous Cardiac Output Trend Solely Utilizing Routine Cardiovascular MonitorsJournal of Clinical Monitoring and Computing, 2004